• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[尿路结石病患者和健康对照者口服草酸盐负荷后的肾草酸盐排泄]

[Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].

作者信息

Ebisuno S, Morimoto S, Yoshida T, Fukatani T, Yasukawa S, Okawa T

出版信息

Hinyokika Kiyo. 1986 Dec;32(12):1773-9.

PMID:3825824
Abstract

Oral oxalate loading using sodium oxalate or a vegetable juice was done to evaluate the intestinal absorption of exogenous oxalate in 30 patients with renal stones and 13 healthy controls. Fifteen calcium oxalate stone formers, 7 non-oxalate stone formers and 10 healthy volunteers were given an oral loading of sodium oxalate (500 mg). Urinary oxalate increased promptly, reaching a peak value within 4 to 8 hours after administration of a synthetic oxalate orally in a fasting state. In calcium oxalate stone formers, the mean increment of urinary oxalate and the bioavailability following oral sodium oxalate load were significantly higher than in the healthy controls and non-oxalate stone formers. Furthermore, intestinal hyperabsorption of oxalate in our criterion was defined in six patients with calcium oxalate stones (40%). On the other hand, eight calcium oxalate stone formers and three healthy controls were given vegetable juice. Urinary oxalate was increased only slightly after the ingestion, and there was no difference between calcium oxalate stone formers and normal controls. These results suggest that a certain hyperoxaluria might be induced by intestinal absorption of exogenous oxalate, and that the hyperabsorption might indicate a possible risk factor for calcium oxalate stone formation.

摘要

采用草酸钠或蔬菜汁进行口服草酸盐负荷试验,以评估30例肾结石患者和13名健康对照者对外源性草酸盐的肠道吸收情况。给15例草酸钙结石形成者、7例非草酸盐结石形成者和10名健康志愿者口服草酸钠(500毫克)。在空腹状态下口服合成草酸盐后,尿草酸盐迅速增加,在给药后4至8小时内达到峰值。在草酸钙结石形成者中,口服草酸钠负荷后尿草酸盐的平均增量和生物利用度显著高于健康对照者和非草酸盐结石形成者。此外,按照我们的标准,6例草酸钙结石患者(40%)存在肠道草酸盐过度吸收。另一方面,给8例草酸钙结石形成者和3名健康对照者饮用蔬菜汁。摄入后尿草酸盐仅略有增加,草酸钙结石形成者与正常对照者之间无差异。这些结果表明,肠道吸收外源性草酸盐可能会诱发一定程度的高草酸尿症,且这种过度吸收可能是草酸钙结石形成的一个潜在危险因素。

相似文献

1
[Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].[尿路结石病患者和健康对照者口服草酸盐负荷后的肾草酸盐排泄]
Hinyokika Kiyo. 1986 Dec;32(12):1773-9.
2
The urinary response to an oral oxalate load in recurrent calcium stone formers.复发性草酸钙结石患者口服草酸盐负荷后的尿液反应。
J Urol. 2003 Jun;169(6):2030-3. doi: 10.1097/01.ju.0000062527.37579.49.
3
Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.肾结石病中的草酸盐代谢,特别涉及钙代谢和肠道吸收。
Scand J Urol Nephrol Suppl. 1989;119:1-53.
4
[Studies of urinary risk factors in urolithiasis].[尿路结石的尿液危险因素研究]
Hinyokika Kiyo. 1985 Jan;31(1):1-15.
5
[Plasma oxalate concentration in calcium oxalate stone formers].
Hinyokika Kiyo. 1984 Oct;30(10):1405-15.
6
[Studies of dietary influence on urinary oxalate in calcium oxalate stone formers].[饮食对草酸钙结石患者尿草酸影响的研究]
Hinyokika Kiyo. 1983 Dec;29(12):1587-603.
7
Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.草酸钙结石患者肠道草酸过度吸收:[13C2]草酸新检测方法的应用
J Am Soc Nephrol. 1999 Nov;10 Suppl 14:S329-33.
8
[Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].[可可对儿童尿液中草酸盐、柠檬酸盐、镁和钙排泄的影响]
Monatsschr Kinderheilkd. 1985 Oct;133(10):754-9.
9
[Oxalate loading test for outpatients with calcium oxalate stones].[草酸钙结石门诊患者的草酸盐负荷试验]
Hinyokika Kiyo. 1986 Mar;32(3):351-60.
10
Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.特发性草酸钙结石患者肠道草酸吸收高于健康对照者:采用[(13)C2]草酸吸收试验进行测量。
J Urol. 2006 May;175(5):1711-5. doi: 10.1016/S0022-5347(05)01001-3.